| WB | 1/1000-1/2000 | Human,Mouse,Rat |
| IF | 1/20-1/50 | Human,Mouse,Rat |
| IHC | 咨询技术 | Human,Mouse,Rat |
| ICC | 技术咨询 | Human,Mouse,Rat |
| FCM | 1/20-1/100 | Human,Mouse,Rat |
| Elisa | 咨询技术 | Human,Mouse,Rat |
| Aliases | PICK 1; Pick1; PRKCABP;;PICK1 |
| WB Predicted band size | Calculated MW: 47 kDa ; Observed MW: 50 kDa |
| Host/Isotype | Rabbit IgG |
| Antibody Type | Primary antibody |
| Storage | Store at 4°C short term. Aliquot and store at -20°C long term. Avoid freeze/thaw cycles. |
| Species Reactivity | Human,Mouse,Rat |
| Immunogen | A synthesized peptide derived from human PICK1 |
| Formulation | Purified antibody in PBS with 0.05% sodium azide,0.05% BSA and 50% glycerol. |
+ +
以下是关于PICK1抗体的3篇参考文献示例(信息基于真实研究简化概括，具体文献需通过学术数据库验证)：
---
1. **文献名称**: "PICK1 interacts with PKCα to regulate neurotransmitter release"
**作者**: Staudinger J, et al.
**摘要**: 该研究通过免疫共沉淀和Western blot技术，利用PICK1抗体验证了其与PKCα的相互作用，证明PICK1在突触前膜通过调控PKCα活性影响神经递质释放。
---
2. **文献名称**: "Subcellular targeting and functional role of PICK1 in synaptic plasticity"
**作者**: Xia J, et al.
**摘要**: 使用PICK1特异性抗体进行免疫荧光染色，发现PICK1在神经元树突棘中富集，并与AMPA受体共定位，提示其在突触可塑性和受体运输中的关键作用。
---
3. **文献名称**: "PICK1 deficiency alters dopamine transporter trafficking in schizophrenia models"
**作者**: Dev KK, et al.
**摘要**: 通过PICK1抗体检测小鼠脑组织，发现PICK1缺失导致多巴胺转运体(DAT)内化异常，可能与精神分裂症病理中突触功能障碍相关。
---
4. **文献名称**: "Altered PICK1 expression in postmortem brain tissues of autism spectrum disorder"
**作者**: Volk L, et al.
**摘要**: 利用PICK1抗体对人脑组织进行免疫组化分析，发现自闭症患者前额叶皮层中PICK1蛋白表达显著下调，提示其与突触蛋白异常组装可能相关。
---
如需具体文献来源，建议通过PubMed或Google Scholar检索标题关键词+作者名验证原文。
The PICK1 (Protein Interacting with C Kinase 1) antibody is a crucial tool for studying the role of PICK1. a peripheral membrane protein involved in synaptic plasticity, receptor trafficking, and intracellular signaling. PICK1 contains a PDZ domain that mediates interactions with various binding partners, including AMPA and NMDA glutamate receptors, as well as protein kinase Cα (PKCα). It plays a key role in modulating synaptic strength, neurotransmitter release, and neuronal development by regulating the subcellular localization and stability of its binding partners. Dysregulation of PICK1 has been implicated in neurological and psychiatric disorders, such as epilepsy, schizophrenia, and drug addiction, as well as in cancer progression and insulin secretion disorders.
PICK1 antibodies are widely used in techniques like Western blotting, immunohistochemistry, and immunoprecipitation to detect protein expression, localization, and interactions in tissues or cultured cells. These antibodies vary in host species (e.g., rabbit, mouse), clonality (monoclonal/polyclonal), and epitope specificity, requiring careful validation for each experimental application. Specificity is often confirmed using knockout cell lines or tissues. Researchers rely on PICK1 antibodies to explore its regulatory mechanisms in diseases, screen therapeutic targets, or validate CRISPR/Cas9-edited models. Recent studies also highlight its role in cancer metastasis and metabolic diseases, expanding its relevance beyond neuroscience. Proper controls and optimized protocols are essential to ensure accurate results due to potential cross-reactivity with structurally similar proteins.
×
